A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

Condition:   Uterine Hemorrhage Interventions:   Drug: Direct oral anticoagulant (DOACs);   Drug: Warfarin Sponsor:   Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials